Uncategorized

VIDEO: BDO’s Aftab Jamil Discusses Significant Changes in Life Sciences Financing

February 12, 2013 OneMedPlace Team 0

Aftab Jamil of BDO spoke with OneMedTV during the 6th Annual OneMedForum in January to discuss the state of life sciences investment, and how companies can formulate new strategies to attract a sustainable class of investors. At the core of these new strategies are the initiatives being implemented to increase access to non-venture capital in the earlier rounds, which may incubate a company long enough to grow a pipeline, attract tenable/diverse revenue opportunity, and eventually reach market.

VIDEO: Aptiv Solutions CEO Discusses Clinical Trials Guidelines, Unmet Need

February 8, 2013 OneMedPlace Team 0

Aside from re-defined financing structures, the most important issue facing life sciences EGCs is the need to increase clinical trial efficiency and productivity so that development budgets are used prudently to support products that have the best chance of market success. Speaking to OneMedTV during OneMedForum this past January, Donnelly discussed current changes that will impact the future of product development and the central role that innovative trial design will play in this.

No Image

Can SpineGuard Shake-Up the $7 Billion Market for Spinal Fusion Using Screws with its Safety Oriented Technology?

January 7, 2013 OneMedPlace Team 0

SpineGuard, based in San Francisco and Paris, is addressing a major unmet need in spine surgery: the safe placement of pedicle screws for both patients and OR personnel. PediGuard®, its core technology, is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches during pedicle screw site preparation.

No Image

Jack Young, Qualcomm Life Sciences Director, Discusses Mobile Health and Patient Management

December 6, 2012 OneMedPlace Team 0

Young’s experience in both sectors makes him a unique voice in the osmosis of venture capital between mobile technology and life sciences. Young will participate in a panel dedicated to the subject at the 6th Annual OneMedForum in San Francisco, January 7-9. OneMedRadio spoke with Jack Young about investing in this sector, and the points of significant unmet medical need which represent the most promising opportunities.

No Image

CEVEC Pharmaceuticals GmbH Raises € 2.8MM in Series C Financing

October 26, 2012 OneMedPlace Team 0

CEVEC Pharmaceuticals GmbH (CEVEC), the developer of a novel human expression system for the manufacturing of complex biopharmaceuticals and vaccines announced today that it raised an additional amount of € 2.8 million in a Series C financing led by Peppermint VenturePartners (PVP) via the new Charité Biomedical Fund.